-+ 0.00%
-+ 0.00%
-+ 0.00%

Market news: General Electric Healthcare Group is in negotiations to acquire cancer contrast agent developer Sophie Biosciences, with a transaction amount of 1 billion US dollars.

Zhitongcaijing·09/13/2026 10:09:00
Listen to the news
Market news: General Electric Healthcare Group is in negotiations to acquire cancer contrast agent developer Sophie Biosciences, with a transaction amount of 1 billion US dollars.